Paramyxoviridae Infections: Clinical Trials

311 completed, 46 unknown, 29 recruiting, 28 terminated. 127 Phase 1, 107 Phase 2, 93 Phase 3, 34 Not applicable, 27 Phase 4.

By phase and status

Phase	Trials	Status
Phase 1	127	Completed 97, Terminated 9, Active not recruiting 7, Recruiting 5, Unknown 4, Withdrawn 3, Not yet recruiting 1, Suspended 1
Phase 2	107	Completed 72, Terminated 11, Recruiting 9, Unknown 7, Active not recruiting 4, Withdrawn 3, Not yet recruiting 1
Phase 3	93	Completed 68, Recruiting 8, Terminated 6, Active not recruiting 4, Unknown 4, Not yet recruiting 2, Withdrawn 1
Not applicable	34	Completed 21, Unknown 9, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 4	27	Completed 19, Unknown 5, Recruiting 2, Not yet recruiting 1

Follow Paramyxoviridae Infections: new trials by email Literature Review of Paramyxoviridae Infections trials Research Report on Paramyxoviridae Infections

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adults Bivalent RSV Vaccine (IN006), Placebo - Respiratory Syncytial Virus Infections	Phase 1	Not yet recruiting	Shenzhen Shenxin Biotechnology Co., Ltd	200	2026-12-01	2026-04-13
Phase 2 Study of SYH2066 Tablets Compared With Placebo in Chinese Adult Patients With Respiratory Syncytial Virus Infection. SYH2066, Placebo - Respiratory Syncytial Virus Infections	Phase 2	Not yet recruiting	CSPC Ouyi Pharmaceutical Co., Ltd.	80	2026-11-13	2026-10-20
Assessment of the Acceptability of, and Factors Associated With, Recommended Vaccinations During Pregnancy in Maternity Units in the Ile-de-France Region Vaccination Coverage Among Pregnant Women		Not yet recruiting	Assistance Publique - Hôpitaux de Paris	1605	2026-11-01	2026-10-20
Evaluating the Benefits of RSV Maternal Vaccination Using a Scottish National Dataset ABRYSVO - Respiratory Syncytial Virus Infections		Not yet recruiting	Pfizer	1	2026-10-15	2026-09-24
The EMBRACE Study: Enflonsia Monoclonal in Babies - RSV Antibody Concentration Evaluation Clesrovimab - RSV Infection	Phase 4	Not yet recruiting	Emory University	24	2026-09-01	2026-09-17
Internal Jugular Vein Respiratory Variability as a Marker of Disease Severity in Infant Bronchiolitis Point-of-Care Ultrasonography - Acute Bronchiolitis, Viral Bronchiolitis		Not yet recruiting	Eskisehir Osmangazi University	120	2026-09-01	2026-08-21
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to Healthy Children 4 to 6 Years of Age MMRVNS vaccine, MMRV vaccine, DTaP-IPV vaccine - Measles, Mumps	Phase 3	Not yet recruiting	GlaxoSmithKline	1860	2026-08-11	2026-08-03
A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus zelicapavir, Placebo - RSV Infection, RSV	Phase 2	Recruiting	Enanta Pharmaceuticals, Inc	150	2026-07-09	2026-07-20
Expression of Inflammatory Markers in the Course of Acute Respiratory Viral Infections SARS CoV 2 Infection, RSV Infections		Not yet recruiting	Fabiana Sherine Ganem dos Santos	150	2026-07-01	2026-06-11
Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older. Recombinant Respiratory Syncytial Virus Vaccine(CHO cell)(Adjuvanted), Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Single adjuvant), Recombinant Respiratory Syncytial Virus Vaccine(CHO cell) (Blank adjuvant) - Respiratory Syncytial Virus Infections	Phase 1 / Phase 2	Recruiting	Ab&B Bio-tech Co., Ltd.JS	470	2026-05-14	2026-05-27
Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France saliva sampling, Nasopharyngeal swab - Respiratory Tract Infections (RTI), Influenza -Like Illness		Recruiting	Institut National de la Santé Et de la Recherche Médicale, France	25000	2026-05-14	2026-08-03
A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Administered as Intramuscular Injection to Healthy Children 15 Months to 6 Years of Age MMRVNS, MMRV - Measles, Measles-Mumps-Rubella+Chickenpox Vaccine	Phase 3	Recruiting	GlaxoSmithKline	1209	2026-05-11	2026-07-08
Risk Factors and Severity of Bronchiolitis in Hospitalized Children at Assiut University Hospital Bronchiolitis, Acute Bronchiolitis		Not yet recruiting	Assiut University	65	2026-05-01	2026-04-01
Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age H5 Flu Investigational Medical Product (IMP) 1, H5 Flu IMP 2, H5 Flu IMP 3 - Respiratory Syncytial Virus (RSV), Influenza A(H5N1)	Phase 1	Recruiting	Sanofi	570	2026-04-15	2026-05-08
Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants Respiratory Syncytial Virus Infection, Bronchiolitis		Not yet recruiting	Phuc Huu Phan	250	2026-04-01	2026-02-18
A Phase III Study of Deuremidevir Hydrobromide for the Treatment of RSV Infection in Infants and Young Children SIM0916, SIM0916 Placebo - Respiratory Syncytial Virus Infection	Phase 3	Recruiting	Simcere Pharmaceutical Co., Ltd	498	2026-03-11	2026-04-02
A Study of Ziresovir (AK0529) in High-risk Adult With Respiratory Syncytial Virus (RSV) Infection. Ziresovir (AK0529), Placebo - Respiratory Syncytial Virus Infections	Phase 2 / Phase 3	Recruiting	Shanghai Ark Biopharmaceutical Co., Ltd.	290	2026-03-03	2026-06-22
the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines Polio, Measles		Not yet recruiting	China National Biotec Group Company Limited	600	2026-01-30	2026-01-14
The Effects of Iron Treatment on Malaria and Measles Vaccine Response in Kenyan Infants With Iron Deficiency Iron syrup, Multivitamin syrup, R21-Matrix/M Vaccine (malaria vaccine) - Iron Deficiencies	Not applicable	Not yet recruiting	Nicole Stoffel	324	2026-01-05	2025-12-26
Unravelling the Measles Paradox in Children MEASLES DISEASE		Not yet recruiting	Erasmus Medical Center	100	2026-01-03	2025-11-26

Showing 20 of 462. Sign in to see all of them.

Narrower conditions

Respiratory Syncytial Virus Infections (302)  ·  Measles (124)  ·  Mumps (81)  ·  Rubella (81)  ·  Chickenpox (45)  ·  Influenza, Human (22)  ·  Respiratory Tract Infections (21)  ·  Virus Diseases (20)  ·  COVID-19 (19)  ·  Bronchiolitis (15)  ·  Whooping Cough (13)  ·  Infections (11)  ·  Pneumonia (10)  ·  Tetanus (10)

Broader conditions

Mononegavirales Infections (461)  ·  RNA Virus Infections (460)  ·  Infections (451)  ·  Virus Diseases (442)  ·  Pneumovirus Infections (302)  ·  Morbillivirus Infections (125)  ·  Respiratory Tract Diseases (83)  ·  Togaviridae Infections (82)  ·  Mouth Diseases (81)  ·  Parotid Diseases (81)  ·  Parotitis (81)  ·  Rubivirus Infections (81)  ·  Rubulavirus Infections (81)  ·  Salivary Gland Diseases (81)

Interventions

measles, mumps, rubella, varicella vaccine (23)  ·  Measles-Mumps-Rubella Vaccine (20)  ·  Chickenpox Vaccine (11)  ·  Measles Vaccine (10)  ·  Saline Solution (9)  ·  EDP-938 (8)  ·  Hepatitis A Vaccines (8)  ·  Rubella Vaccine (8)  ·  Palivizumab (7)  ·  Vaccines (7)  ·  nirsevimab (7)  ·  sisunatovir (7)  ·  ziresovir (7)  ·  4'-chloromethyl-2'-deoxy-3',5'-di-O-isobutyryl-2'-fluorocytidine (6)  ·  Heptavalent Pneumococcal Conjugate Vaccine (5)

Sponsors

GlaxoSmithKline (63)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (34)  ·  Merck Sharp & Dohme LLC (21)  ·  Sanofi Pasteur, a Sanofi Company (15)  ·  Enanta Pharmaceuticals, Inc (14)  ·  Pfizer (13)  ·  MedImmune LLC (10)  ·  Gilead Sciences (8)  ·  Bandim Health Project (7)  ·  Shanghai Ark Biopharmaceutical Co., Ltd. (7)  ·  Bavarian Nordic (6)  ·  The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (6)  ·  Alios Biopharma Inc. (5)  ·  Assistance Publique - Hôpitaux de Paris (5)  ·  Hospices Civils de Lyon (5)

Countries

United States (189)  ·  United Kingdom (56)  ·  China (47)  ·  Australia (46)  ·  Spain (40)  ·  France (36)  ·  Germany (33)  ·  Canada (31)  ·  Belgium (29)  ·  Japan (29)  ·  South Africa (29)  ·  Finland (26)  ·  Italy (26)  ·  Poland (23)  ·  South Korea (21)

Top investigators

Ruth A. Karron, MD (13)  ·  Anna Novotney-Barry (3)  ·  Oliver Medzihradsky, MD MPH MS (3)

Results publications

PMID 31951765, PMID 34774184, PMID 38921800, PMID 29401325, PMID 29509911, PMID 29509929, PMID 31211158, PMID 32813276, PMID 37468530, PMID 38902186, PMID 10342702, PMID 11228365, PMID 11672911, PMID 12443658, PMID 12798618, PMID 14506371, PMID 14722149, PMID 15082642, PMID 15188713, PMID 15356783, PMID 15626943, PMID 15659474, PMID 16094218, PMID 16390959, PMID 16452343, PMID 16567978, PMID 16804432, PMID 17060336, PMID 17156899, PMID 17332177, PMID 17502347, PMID 17541638, PMID 17938165, PMID 18477402, PMID 18653640, PMID 18676537, PMID 19196675, PMID 19303808, PMID 19305145, PMID 19366435, PMID 19663708, PMID 19712484, PMID 19782998, PMID 19923206, PMID 20008423, PMID 20492042, PMID 20525274, PMID 20851929, PMID 20955461, PMID 21118875

NIH funding

2023 (9), 2014 (6), 2018 (6), 2019 (6), 2016 (5), 2025 (3), 2015 (2), 2017 (2), 5UM1AI148684-04 (1), R01AI070018 (1), R01AI179874 (1), R01HD105678 (1)